BiotechTube
Home/Sonnet BioTherapeutics/Pankaj Mohan, Ph.D.
PM

Pankaj Mohan, Ph.D.

Founder, Chief Executive Officer & Chairman

Sonnet BioTherapeutics

Therapeutic Areas

OncologyNeurology

Sonnet BioTherapeutics Pipeline

DrugIndicationPhase
SON-1010Solid TumorsPhase 1
SON-1010 + AtezolizumabPlatinum-Resistant Ovarian Cancer (PROC)Phase 1
SON-1210Solid TumorsPreclinical/Phase 1 planning
SON-080Chemotherapy-Induced Peripheral Neuropathy (CIPN)Phase 2 (planned)